Last Funding Type: Post-IPO Equity
Total Funding: 1741003260.0
Last Funding Date: 2022-04-14
Funding Status: IPO
Number Of Exists: N/A
Employee Number: N/A
Estimated Revenue: $100M to $500M
Technology: COVID
Investors Number: 4
Founded Date: 2008-01-01
Headquarters: Mainz, Rheinland-Pfalz, Germany
Investment Stage: N/A
Industry: mRNA-based Cancer Vaccines
Investor Type: N/A
Acquisitions Number: Made Acquisitions